Skip to main content
. 2017 Nov 28;1:12. doi: 10.1186/s41687-017-0019-0

Table 2.

Descriptive statistics of PROMIS instruments and qDASH of patients

Instrument n Mean (SD) Range Median
Baseline
 PROMIS PF 254 45.45 (9.53) 23.47–70.25 43.18
 PROMIS PI 254 60.85 (7.34) 38.67–80.96 61.52
 PROMIS UE 254 32.48 (9.28) 14.66–56.39 32.13
 qDASH 255 50.09 (22.53) 4.54–97.73 50.00
3-month follow-up
 PROMIS PF 31 50.61 (10.73) 33.10–50.61 51.45
 PROMIS PI 31 52.77 (8.62) 38.67–71.60 52.57
 PROMIS UE 28 36.89 (10.14) 18.34–56.39 36.53
 qDASH 29 33.39 (23.74) 2.27–79.54 27.27
>3-month follow-up
 PROMIS PF 151 46.34 (8.76) 24.07–73.28 47.41
 PROMIS PI 177 56.20 (8.47) 38.67–80.07 55.98
 PROMIS UE 148 34.95 (8.30) 18.34–56.39 35.09
 qDASH 149 39.73 (22.76) 2.27–97.72 36.36
6-month follow-up
 PROMIS PF 18 47.70 (5.59) 32.60–56.06 47.83
 PROMIS PI 20 55.94 (3.46) 50.12–62.64 55.10
 PROMIS UE 18 35.62 (8.13) 18.35–56.26 35.85
 qDASH 18 34.84 (16.16) 11.36–77.27 35.23
>6-month follow-up
 PROMIS PF 53 44.51 (10.23) 2.84–70.25 44.72
 PROMIS PI 62 56.77 (8.87) 38.67–79.99 55.98
 PROMIS UE 52 33.77 (8.66) 17.74–56.39 34.54
 qDASH 55 41.79 (25.67) 6.82–93.18 36.36